ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Forgot password
  • Home
  • Favipiravir versus arbidol for COVID-19: a randomized clinical trial

Favipiravir versus arbidol for COVID-19: a randomized clinical trial

27 Apr 2020 5:07 PM | Daniel Hawley (Administrator)

Original Paper: https://www.medrxiv.org/content/10.1101/2020.03.17.20037432v3

Chen C, Huang J, Yin P, et al.

View Journal Club Review


Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888 • sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software